Boehringer May Face More Sanctions In Pradaxa MDL

Law360, New York (December 19, 2013, 6:15 PM ET) -- A week after hitting Boehringer Ingelheim International GmbH with a nearly $1 million penalty for discovery abuses, an Illinois federal judge ruled Wednesday that the drugmaker may be slapped with even more sanctions in multidistrict litigation over its blood thinner Pradaxa.

BII, the German parent of fellow defendant Boehringer Ingelheim Pharmaceuticals Inc., informed U.S. District Judge David Herndon on Monday that it has access to the so-called user share for a former employee, Thorstein Lehr, even though it had previously said the file was unavailable. In...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required